The prescription of isotretinoin to women: is every precaution taken?

@article{Holmes1998ThePO,
  title={The prescription of isotretinoin to women: is every precaution taken?},
  author={Holmes and Bankowska and Mackie},
  journal={British Journal of Dermatology},
  year={1998},
  volume={138}
}
A questionnaire survey of dermatologists practising in Scotland was carried out to assess strategies for the management of women prescribed isotretinoin for acne. The results of the study suggested that the prevention of pregnancy during treatment is of considerable concern to dermatologists: over 90% routinely asked women about sexual activity and 97% routinely gave both verbal and written advice on the need to avoid pregnancy during treatment. However, clinical practices which might place… 

Knowledge of Safety Rules during Isotretinoin Acne Treatment – Survey in Women in Childbearing Age from Polish Population

The results of the study indicate that the majority of females gained some information about sideeffects, basic safety rules and teratogenicity of isotretinoin, Nevertheless, women do not fully understand the risks of the treatment and underestimate necessary precautions, mainly those regarding pregnancy exclusion and effective contraception.

Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review

The isotretinoin PPP must be scrutinized to identify whether new measures should be taken or whether the failures in the implementation need to be corrected, and to take into account the definition of the ultimate goal of a PPP and the acceptable burden.

Concerns and awareness of acne patients about isotretinoin in qassim region of saudi arabia.

The importance of health education for better acceptance of Isotretinoin is highlighted, patients should be instructed about proper moisturization methods while using this drug.

Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.

This first non-interventional population-based study generated incidence rates of pregnancy while on isotretinoin four times greater than what has been reported in the literature thus far; elective abortion rates were also much higher in the study.

The Return of Thalidomide

There is a need to develop nonteratogenic analogues of thalidomide that can provide effective treatment for erythema nodosum leprosum and other serious conditions without increasing the potential for another epidemic of th Khalidomide-related birth defects.

Continued occurrence of Accutane-exposed pregnancies.

The increase in Accutane use observed among females may be exacerbated by advertising, and Physicians and patients must use more caution with teratogenic prescription drugs.

The diagnostic accuracy of strategies used to identify early pregnancy: a systematic review.

This review will consider studies that compare the diagnostic accuracy of screening strategies to identify early pregnancy compared to HCG pregnancy test.

The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures

Current electronic healthcare databases do not contain all the data necessary to fully monitor the effectiveness of PPP implementation, and thus, special data collection measures need to be instituted.

Defectos congénitos secundarios al uso de isotretinoína oral: comunicación de un caso

It is worrisome to expect more cases of isotretinoin embryopathy in the future since its prescription has been extended for trivial conditions, and one of the adverse effects is the teratogenicity.

Carrier-Based Drug Delivery System for Treatment of Acne

This paper emphasizes approaches to overcome the drawbacks and limitations associated with the conventional system and the advances and application that are poised to further enhance the efficacy of topical acne formulations, offering the possibility of simplified dosing regimen that may improve treatment outcomes using novel delivery system.

References

SHOWING 1-10 OF 20 REFERENCES

Terminations of Pregnancy for Exposure to Oral Retinoids in South Australia, 1985–1993

Extension of guidelines for prescription and more detailed counselling in relation to the use of contraception are recommended and doctors intending to recommend terminations obtain consent to discuss exposure with the dermatologists concerned, who may not be aware of the exposed pregnancy.

A pregnancy-prevention program in women of childbearing age receiving isotretinoin.

The pregnancy rate among women receiving isotretinoin therapy was substantially lower than that in the general population and was compatible with the characteristics and behavior of the enrolled women.

Guidelines for optimal use of isotretinoin in acne.

Current indications for isotretinoin as a treatment for acne vulgaris.

Patients who show only partial response to conventional antibiotic therapy should be prescribed isotretinoin in order to minimize scarring and significant psychological disturbance, independently of the severity of the acne.

The cost of atopic eczema

A community study in a semi‐rural area to assess the economic impact of atopic eczema found that each patient spent, on average, £325 in 2 months, and lead to a mean health service expenditure per patient of £415, in two months.

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study

Risks of venous thromboembolism was slightly increased in users of third generation oral contraceptives compared with users of second generation products and the need for clinical prudence is indicated but doctors and women seeking contraception should exercise informed choice.

Retinoic acid embryopathy.

It is possible that a major mechanism of isotretinoin teratogenesis is a deleterious effect on cephalic neural-crest cell activity that results in the observed craniofacial, cardiac, and thymic malformations.